CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet’s uveitis
- 143 Downloads
- 15 Citations
Abstract
We report the case of a patient with Behçet’s uveitis who developed cytomegalovirus (CMV) retinitis after intravitreal triamcinolone acetonide (IVTA) injection. We reviewed the patient’s chart for the purpose of this report. An IVTA injection was performed for treatment of severe panuveitis in the left eye of a 30-year-old male patient with Behçet’s disease. Systemic treatment included high dose corticosteroid and azathioprine. Fourteen weeks after IVTA, extensive areas of necrotizing retinitis developed in the left eye. Polymerase chain reaction of serum and vitreous samples was positive for CMV DNA. Serum anti-CMV IgG was positive, IgM was negative, anti-HIV antibody was negative, complete blood count was normal, and CD4 count was 1,060 cells/μl. The patient responded well to intravitreal ganciclovir injection performed twice and intravenous ganciclovir treatment administered for five weeks. Local immunosuppression with IVTA may cause CMV retinitis. Awareness of this serious complication is important for correct diagnosis and treatment.
Keywords
Cytomegalovirus retinitis Behçet’s disease Intravitreal triamcinolone acetonide injection Ganciclovir ImmunocompetentReferences
- 1.Wiegand TW, Young LH (2006) Cytomegalovirus retinitis. Int Ophthalmol Clin 46:91–110CrossRefPubMedGoogle Scholar
- 2.Sloan DJ, Taegtmeyer M, Pearce IA et al (2008) Cytomegalovirus retinitis in the absence of HIV or immunosuppression. Eur J Ophthalmol 18:813–815PubMedGoogle Scholar
- 3.Stewart MW, Bolling JP, Mendez JC (2005) Cytomegalovirus retinitis in an immunocompetent patient. Arch Ophthalmol 123:572–574CrossRefPubMedGoogle Scholar
- 4.Ufret-Vincenty RL, Singh RP, Lowder C, Kaiser PK (2007) Cytomegalovirus retinitis after fluocinolone acetonide (RetisertTM) implant. Am J Ophthalmol 143:334–335CrossRefPubMedGoogle Scholar
- 5.Delyfer MN, Rougier MB, Hubschman JP et al (2007) Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. Acta Ophthalmol Scand 85:681–683CrossRefPubMedGoogle Scholar
- 6.Saidel MA, Berreen J, Margolis TP (2005) Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol 140:1141–1143CrossRefPubMedGoogle Scholar
- 7.Park YS, Byeon SH (2008) Cytomegalovirus retinitis after ıntravitreous triamcinolone ınjection in a patient with central retinal vein occlusion. Korean J Ophthalmol 22:143–144CrossRefPubMedGoogle Scholar
- 8.Sekiryu T, Iida T, Kaneko H, Saito M (2008) Cytomegalovirus retinitis after ıntravitreal triamcinolone acetonide in an ımmunocompetent patient. Jpn J Ophthalmol 52:407–425CrossRefGoogle Scholar
- 9.Tuncer S, Yilmaz S, Urgancıoglu M, Tugal-Tutkun I (2007) Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behçet disease. J Ocul Pharmacol Ther 23:395–401CrossRefPubMedGoogle Scholar
- 10.Mikami S, Nakase H, Ueno S et al (2007) Involvement of cytomegalovirus infection in the ileal lesions of the patient with Behçet’s disease. Inflamm Bowel Dis 13:802–803CrossRefPubMedGoogle Scholar
- 11.Aggermann T, Stolba U, Brunner S, Binder S (2006) Endophthalmitis with retinitis following intravitreal triamcinolone acetonide injection. Ophthalmologica 220:131–133CrossRefPubMedGoogle Scholar
- 12.Toh T, Borthwick JH (2006) Acute retinal necrosis post intravitreal injection of triamcinolone acetonide. Clin Exp Ophthalmol 34:380–382CrossRefGoogle Scholar